Daxor Corporation , the global leader in blood volume measurement technology, announces the opening of a new BVA program at a premier Florida healthcare center in the Tampa Bay region. This expansion integrates Daxor’s innovative blood volume analysis testing across the facility’s inpatient and outpatient care programs, revolutionizing fluid management precision and enhancing treatment outcomes for a spectrum of conditions.
The facility will utilize Daxor’s state-of-the-art Tennessee-based CLIA-certified ezBVA Lab that delivers comprehensive blood volume analysis results within 24 hours of sample receipt.
Health Technology Insights: Adeptia Announces the Release of Adeptia Connect v5
“This exciting hallmark marks another significant milestone in our ongoing Florida expansion and underscores the critical role of precise volume assessment in patient care,” said Michael Feldschuh, Daxor’s CEO and President. “Our diagnostic technology provides clinicians with 98% accurate measurements, enabling tailored fluid management strategies for cardiac conditions, renal disease, critical care, and other volume-sensitive disorders. This approach significantly improves patient outcomes while reducing healthcare costs. Our ezBVA Lab service eliminates the need for capital investment while remaining fully reimbursable through established CPT codes under both public and private insurance plans for all care settings.”
Health Technology Insights: Carenet Health Opens First Dedicated Facility in the Philippines
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – GlobeNewswire
